Oct 21 2022
Cannabidiol (CBD) mitigated the neuronal damage caused by kainate in an in-vitro seizure model, according to a new study published in the peer-reviewed journal Neurobiology of Disease. The study states that epilepsy “is one of the most common brain disorder and, despite the possible use of several therapeutic options, many patients continue to have seizures …
Oct 21 2022
A new study has found that cannabis extracts “may be of value to treat dermatophytosis and other skin diseases caused by various microorganisms.” Published in the journal Frontiers in Microbiology, the study was conducted by researchers at the Czech University of Life Sciences Prague and Charles University, both in Czechia. “Cannabis preparations are gaining popularity …
Oct 21 2022
An International Journal of Molecular Sciences study has found that cannabinoids have a toxic effect on colon polyps, indicating therapeutic potential in battling colon cancer cells. “Purified cannabinoids have been shown to prevent proliferation and induce apoptosis in colorectal carcinoma cell lines”, claims the abstract of the study. The primary objective was to “assess the …
Oct 20 2022
The anxiolytic (anti-anxiety) effects of CBD in frontline health care professionals during the COVID-19 pandemic were maintained up to 1 month after the treatment discontinuation, “suggesting a persistent decrease in anxiety in this group in the real world”. This is according to a new study published by the journal Frontiers in Pharmacology, and epublished by …
Oct 20 2022
A new study published in the journal PLOS One has found that terminal cancer patients with refractory pain respond favorably to a marijuana spray containing equal parts THC and CBD. “This pilot study aimed to assess the safety, tolerability, pharmacokinetics and exploratory analgesic effect of a novel water-soluble oro-buccal nanoparticle spray of a cannabis-based medicine …
Oct 20 2022
Low-dose THC “has a positive effect on morbidity, side effects, quality of life and mortality in geriatric and palliative patients”, according to a new study. The study was published by the peer-reviewed journal peer-reviewed journal MMW – Fortschritte der Medizin, as well as on the website for the U.S. National Library of Medicine. “Cannabis-containing medicines …
Oct 20 2022
A long-term THC/CBD medication “can be administered safely and with overall positive clinical improvement to poly medicated older adults with severe dementia and associated problems.” This is according to a new study published in the peer-reviewed journal Frontiers in Aging Neuroscience, and conducted by researchers in Switzerland. “The management of behavioral symptoms and rigidity in …
Oct 19 2022
The findings of a new study “indicate that CBD might be beneficial in alleviating UVB-induced skin damage in humans.” The study was published in the peer-reviewed journal Molecules, and was epublished by the U.S. National Institute of Health. It was conducted by researchers at Sichuan University in China. “Cannabidiol (CBD) has emerged as a phytocannabinoid …
Oct 18 2022
A new study being published in the journal Pharmacological Reports has found that the marijuana compound cannabidiol (CBD) is effective against brainstem and limbic seizures. “Cannabidiol (CBD) has been of rapidly growing interest in the epilepsy research field due to its antiseizure properties in preclinical models and patients with pharmacoresistant epilepsy”, states the study, which …
Oct 18 2022
Cannabinoids may serve as an effective treatment option for hyperhidrosis, according to a new study published by the Journal of Dermatological Treatment. Hyperhidrosis is described by the Mayo Clinic as “abnormally excessive sweating involving the extremities, underarms, and face, usually unrelated to body temperature or exercise, and it effects about 1% of the population. “Hyperhidrosis …
